Skip to main
DOCS
DOCS logo

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 18 analyst ratings
Hold
Strong Buy 11%
Buy 39%
Hold 39%
Sell 6%
Strong Sell 6%

Bulls say

Doximity Inc. has experienced a significant growth in its POC and formulary offerings, with an increase of more than 100% during the last buying season, showcasing strong demand for its specialized digital tools tailored for medical professionals. The company's shares have shown positive momentum, rising 3.2% since September 8, which indicates growing investor confidence. Additionally, the second quarter guidance appears attainable with potential for upside, suggesting robust operational performance and increasing visibility in the market driven by expanded product offerings.

Bears say

Doximity's stock has a negative outlook due to uncertainty in the economic environment, which has prompted downward guidance revisions from its pharmaceutical clients for fiscal years 2023 and 2024. Additionally, Doximity's shares are perceived as expensive when compared to its software peers, suggesting potential volatility if the company fails to meet high investor expectations. There is heightened scrutiny regarding the company's financial performance, and any inability to deliver positive results or raise guidance could lead to significant disappointment among investors.

Doximity (DOCS) has been analyzed by 18 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 39% recommend Buy, 39% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Hold based on their latest research and market trends.

According to 18 analysts, Doximity (DOCS) has a Hold consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $70.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $70.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.